Illumina ILMN Management Strategy Q4 2025 Better Than Expected BDX BD notches narrow Q1 2026 EPS beat shares drop 175 percent amid soft investor sentiment SILO Silo Pharma rises 557 percent despite reporting a wider than expected Q4 2023 per share loss